Betamethasone and aqueous extract of Arctium lappa for treating angiostrongyliasis;Betametasona e extrato aquoso de Arctium lappa no tratamento da angiostrongilíase

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 6, 2008, Pages 654-657

  Fante, Camila Argenta ^a,b   Dieterish, Solange ^a   Rodriguez, Rubens ^a  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b NONE   (Brazil)

Author keywords

Angiostrongyliasis; Anti inflammatory drugs; Arctium lappa; Betamethasone

Indexed keywords

ANTIINFLAMMATORY AGENT; ARCTIUM LAPPA EXTRACT; BETAMETHASONE; UNCLASSIFIED DRUG;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCTIUM; ARCTIUM LAPPA; ARTICLE; CELL INFILTRATION; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; EOSINOPHIL; GRANULOMA; INTESTINE INJURY; MALE; MOUSE; NONHUMAN; SWISS WEBSTER MOUSE; TREATMENT FAILURE;

ANGIOSTRONGYLUS COSTARICENSIS; ARCTIUM LAPPA; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARCTIUM; BETAMETHASONE; DISEASE MODELS, ANIMAL; MALE; MICE; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX; STRONGYLIDA INFECTIONS;

EID: 59349101079     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000600018     Document Type: Article

References (13)

1. Cespedes R, Salas J, Mekbel S, Troper L, Mullner F, Morera P. Granulomas entéricos y linfáticos com intensa eosinofilia tisular producidos por um estrongilídeo (Strongylata). Acta Médica Costarricense 10: 235-255, 1967.
2. Der DP, Coll CN, Hsiang JT. Activity of burdock (Arctium lappa Linne): Its scavenging effect on free-radical and active oxygen. Journal American Oil Chemists Society 75: 455-461, 1998.
3. a edição, Editora Guanabara Koogan, Rio de Janeiro p. 1077-1079, 2005.
4. Graeff-Teixeira C, Coura L, Lenzi H. Abdominal Angiostrongyliasis - an under diagnosed disease. Memórias do Instituto Oswaldo Cruz 82: 353-354, 1987.
5. Grases F, Melero G, Costa-Bauza A, Prieto R, March JG. Urolithiasis and Phytotherapy. International Urology and Nephrology 26: 507-511, 1994.
6. Hwang L, Leichter R, Okamoto A, Payan D, Collins SM, Bunnett NW. Downregulation of neutral endopeptidase in the inflamed rat intestine. American Physiological Society 264: 735-743, 1993.
7. Lin CC, Lin JM, Yang JJ. Anti-inflamatory and radical scavenger: Effects os Arctium lappa. The American Journal of Chinese Medicine 24: 127-137, 1996.
8. Morera P, Bontempo I. Accion de algunos anthihelminticos sobre Angiostrongylus costaricensis. Revista Médica del Hospital Nacional de Ninõs 20: 165-174, 1986.
9. Moreira P, Perez F, Mora F, Castro L. Visceral larva migrans-like syndrome caused by Angiostrongylus costaricensis. The American Journal of Tropical Medicine and Hygiene 31: 67-70, 1982.
10. Pena MP, Andrade Filho J, Assis SC. Angiostrongylus costaricensis: First record of its occurrence in the state of Espírito Santo, Brazil, and a revieco of its geographic distribution. Revista do Instituto de Medicina Tropical de São Paulo 37: 369-374, 1995.
11. Robles G, Loria R, Lobo F. Granuloma Eosinófilo Parasitário Intestinal. Revista Médica del Hospital Nacional de Ninõs 3: 67-80, 1968.
12. Sanahuja F, Cortês R, Gonzalez G. Angiostrongilosis Abdominal. Aspectos clínicos, tratamiento y revisión de la literatura. Boletin Médico del Hospital Infantil de Mexico 44: 4-9, 1987.
13. a edição, Editora Guanabara Koogan, Rio de Janeiro, p. 294-295, 2004.